Elliott L Franklyn, Chu Carrie K, Daniel Jarrod, Harper Garrett, Bergey Patricia
From the *Atlanta Plastic Surgery, Atlanta, GA; and †Division of Plastic Surgery, Emory University School of Medicine, Atlanta, GA.
Ann Plast Surg. 2014;72(6):S103-6. doi: 10.1097/SAP.0000000000000088.
Prior breast augmentation in patients desiring post-mastectomy reconstruction provides a unique opportunity for capsular preservation and immediate, single-step implant reconstruction. We report a case series of a single-surgeon experience with immediate implant reconstruction after skin-sparing mastectomy in patients with prior subpectoral augmentation. Final implant volumes, complications, and outcomes were examined. Twenty patients (15 bilateral, total 35 breasts) were included. Eighteen (90%) patients were treated for cancer. Mean augmentation-to-reconstruction interval was 9 years (range, 3-19 years). Mean patient age was 45.1 years (range, 37-64 years). Eight patients (40%) received postoperative chemotherapy and two (10%) radiation. Mean mastectomy weight was 321 g. Mean weight of the implants removed was 346 g. Mean volume of new implants was 487 mL. All patients underwent capsulotomy (100% superior, 85% medial, 30% inferior, 5% lateral). Mean operative time was less than 1 hour for bilateral reconstruction. With average follow-up of 25.6 months, 2 patients were re-operated on for asymmetry (implant malposition, synmastia). Thirty-day complications included 1 implant loss due to infection, 1 drain placement with implant salvage, 1 hematoma requiring evacuation, and 1 cellulitis treated with antibiotics. There were no late complications and no capsular contractures. None have required further oncologic surgery. No cancer recurrences have been detected. In patients who desire prosthetic reconstruction similar to their original submuscular augmentation, capsule preservation and implant replacement with a larger prosthetic inserted within the old capsule is safe, fast, and aesthetically pleasing without compromising oncologic principles.
对于希望在乳房切除术后进行重建的患者,先前的隆胸手术为保留包膜以及立即进行单步植入物重建提供了独特的机会。我们报告了一组病例系列,是一位外科医生对先前进行胸肌下隆胸的患者在保乳乳房切除术后立即进行植入物重建的经验。研究了最终植入物体积、并发症和结果。纳入了20例患者(15例双侧,共35个乳房)。18例(90%)患者因癌症接受治疗。隆胸至重建的平均间隔时间为9年(范围3 - 19年)。患者平均年龄为45.1岁(范围37 - 64岁)。8例(40%)患者接受了术后化疗,2例(10%)接受了放疗。平均乳房切除重量为321克。取出的植入物平均重量为346克。新植入物的平均体积为487毫升。所有患者均接受了包膜切开术(100%为上方,85%为内侧,30%为下方,5%为外侧)。双侧重建的平均手术时间少于1小时。平均随访25.6个月,2例患者因不对称(植入物位置异常、乳房融合)接受了再次手术。30天内的并发症包括1例因感染导致的植入物丢失、1例通过植入物挽救进行的引流管放置、1例需要引流的血肿以及1例用抗生素治疗的蜂窝织炎。没有晚期并发症,也没有包膜挛缩。没有人需要进一步的肿瘤手术。未检测到癌症复发。对于希望进行类似于其原始肌下隆胸的假体重建的患者,保留包膜并在旧包膜内插入更大的假体进行植入物置换是安全、快速且美观的,同时不影响肿瘤学原则。
J Plast Reconstr Aesthet Surg. 2013-8-6
J Plast Reconstr Aesthet Surg. 2014-7-31
Aesthetic Plast Surg. 2016-10
Aesthet Surg J Open Forum. 2025-5-26
Clin Breast Cancer. 2020-2